In silico investigation of cytochrome bc1 molecular inhibition mechanism against Trypanosoma cruzi.
Chagas' disease is a neglected tropical disease caused by the kinetoplastid protozoan Trypanosoma cruzi. The only therapies are the nitroheterocyclic chemicals nifurtimox and benznidazole that cause various adverse effects. The need to create safe and effective medications to improve medical ca...
Saved in:
Main Authors: | Stefano Muscat (Author), Gianvito Grasso (Author), Leonardo Scapozza (Author), Andrea Danani (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EPIDEMIOLOGÍA MOLECULAR DE TRYPANOSOMA CRUZI
by: Felipe Guhl
Published: (2013) -
Molecular and antigenic characterization of Trypanosoma cruzi TolT proteins.
by: Maite Lobo, et al.
Published: (2019) -
Biology of Trypanosoma cruzi: An update Biología del Trypanosoma cruzi: Actualización
by: André Vianna Martins, et al.
Published: (2012) -
Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of Trypanosoma cruzi infection
by: da Silva CF, et al.
Published: (2017) -
Molecular and functional characterization of a Trypanosoma cruzi nuclear adenylate kinase isoform.
by: María de los Milagros Cámara, et al.
Published: (2013)